Abstract
Objectives
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by the presence of autoantibodies that are used for classification of the disease. Though routine diagnostics is commonly restricted to measuring rheumatoid factor (RF) and anti-citrullinated protein antibodies, detection of RF IgM, IgG and IgA isotypes, may increase the power of RA serodiagnosis by reducing the number of seronegative patients as well as provide prognostic information. The agglutination-based RF assays, such as nephelometry or turbidimetry, are unable to differentiate isotypes. We compared three different immunoassays used in current laboratory practice to detect RF isotypes.
Methods
We tested 117 consecutive serum samples that were positive for total RF at nephelometry, from 55 RA and 62 non-RA subjects. IgA, IgG, and IgM isotypes of RF were tested by immunoenzymatic (ELISA, Technogenetics), fluoroenzymatic (FEIA, ThermoFisher) and chemiluminescence (CLIA, YHLO Biotech Co.) immunoassays.
Results
Diagnostic performance differed considerably between the assays, especially with regard to RF IgG isotype. Agreement among methods by Cohen’s kappa ranged from 0.05 (RF IgG CLIA vs. FEIA) to 0.846 (RF IgM CLIA vs. FEIA).
Conclusions
The poor agreement observed in this study indicates substantial lack of comparability among assays for RF isotypes. Harmonization of these tests requires further efforts before their measurement can be used in clinical practice.
-
Research funding: None declared.
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Not applicable.
-
Ethical approval: Not applicable.
References
1. Haberman, AM, William, J, Euler, C, Shlomchik, MJ. Rheumatoid factors in health and disease: structure, function, induction and regulation. Curr Dir Autoimmun 2003;6:169–95. https://doi.org/10.1159/000066861.Search in Google Scholar PubMed
2. Rantapää-Dahlqvist, S, de Jong, BA, Berglin, E, Hallmans, G, Wadell, G, Stenlund, H, et al.. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741–9. https://doi.org/10.1002/art.11223.Search in Google Scholar PubMed
3. Berglin, E, Johansson, T, Sundin, U, Jidell, E, Wadell, G, Hallmans, G, et al.. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 2006;65:453–8. https://doi.org/10.1136/ard.2005.041376.Search in Google Scholar PubMed PubMed Central
4. Conrad, K, Roggenbuck, D, Reinhold, D, Dörner, T. Profiling of rheumatoid arthritis associated autoantibodies. Autoimmun Rev 2010;9:431–5. https://doi.org/10.1016/j.autrev.2009.11.017.Search in Google Scholar PubMed
5. Nell-Duxneuner, V, Machold, K, Stamm, T, Eberl, G, Heinzl, H, Hoefler, E, et al.. Autoantibody profiling in patients with very early rheumatoidarthritis: a follow-up study. Ann Rheum Dis 2010;69:169–74. https://doi.org/10.1136/ard.2008.100677.Search in Google Scholar PubMed
6. Bos, WH, Wolbink, GJ, Boers, M, Tijhuis, GJ, de Vries, N, van der Horst-Bruinsma, IE, et al.. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis 2010;69:490–4. https://doi.org/10.1136/ard.2008.105759.Search in Google Scholar PubMed
7. Aletaha, D, Neogi, T, Silman, AJ, Funovits, J, Felson, DT, COr, B, et al.. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580–8. https://doi.org/10.1136/ard.2010.138461.Search in Google Scholar PubMed
8. Falkenburg, WJJF, von Richthofen, HJ, Koers, J, Weykamp, C, Schreurs, MWJ, Bakker-Jonges, LE, et al.. Clinically relevant discrepancies between different rheumatoid factor assays. Clin Chem Lab Med 2018;56:1749–58. https://doi.org/10.1515/cclm-2017-0988.Search in Google Scholar PubMed
9. Brink, M, Hansson, M, Mathsson-Alm, L, Wijayatunga, P, Verheul, MK, Trouw, LA, et al.. Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis. Arthritis Res Ther 2016;18:43. https://doi.org/10.1186/s13075-016-0940-2.Search in Google Scholar PubMed PubMed Central
10. van Hoovels, L, Jacobs, J, vander Cruyssen, B, van den Bremt, S, Verschueren, P, Bossuyt, X. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis. Ann Rheum Dis 2018;77:667–77. https://doi.org/10.1136/annrheumdis-2017-212365.Search in Google Scholar PubMed
11. Rönnelid, J, Turesson, C, Kastbom, A. Autoantibodies in rheumatoid arthritis – laboratory and clinical perspectives. Front Immunol 2021;12:685312. https://doi.org/10.3389/fimmu.2021.685312.Search in Google Scholar PubMed PubMed Central
12. van Hoovels, L, Studenic, P, Sieghart, D, Steiner, G, Bossuyt, X, Rönnelid, J. Impact of autoimmune serology test results on RA classification and diagnosis. J Transl Autoimmun 2022;5:100142. https://doi.org/10.1016/j.jtauto.2022.100142.Search in Google Scholar PubMed PubMed Central
13. Vallbracht, I, Rieber, J, Oppermann, M, Förger, F, Siebert, U, Helmke, K. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 2004;63:1079–84. https://doi.org/10.1136/ard.2003.019877.Search in Google Scholar PubMed PubMed Central
14. Jónsson, T, Valdimarsson, H. Is measurement of rheumatoid factor isotypes clinically useful? Ann Rheum Dis 1993;52:161–4. https://doi.org/10.1136/ard.52.2.161.Search in Google Scholar PubMed PubMed Central
15. Sieghart, D, Platzer, A, Studenic, P, Alasti, F, Grundhuber, M, Swiniarski, S, et al.. Determination of autoantibody isotypes increases the sensitivity of serodiagnostics in rheumatoid arthritis. Front Immunol 2018;24:876. https://doi.org/10.3389/fimmu.2018.00876.Search in Google Scholar PubMed PubMed Central
16. Martinez-Prat, L, Nissen, MJ, Lamacchia, C, Bentow, C, Cesana, L, Roux-Lombard, P, et al.. Comparison of serological biomarkers in rheumatoid arthritis and their combination to improve diagnostic performance. Front Immunol 2018;9:1113. https://doi.org/10.3389/fimmu.2018.01113.Search in Google Scholar PubMed PubMed Central
17. Motta, F, Bizzaro, N, Giavarina, D, Franceschini, F, Infantino, M, Palterer, B, et al.. Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis – a systematic review and meta-analysis. RMD Open 2023.10.1136/rmdopen-2022-002817Search in Google Scholar PubMed PubMed Central
18. Bampton, JL, Cawston, TE, Kyle, MV, Hazleman, BL. Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. Ann Rheum Dis 1985;44:13–9. https://doi.org/10.1136/ard.44.1.13.Search in Google Scholar PubMed PubMed Central
19. Swedler, W, Wallman, J, Froelich, CJ, Teodorescu, M. Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity and predictive value for rheumatoid arthritis. J Rheumatol 1997;24:1037–44.Search in Google Scholar
20. Jónsson, T, Steinsson, K, Jonsson, H, Geirsson, AJ, Thorsteinsson, J, Valdimarsson, H. Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis. Rheumatol Int 1998;18:119–22. https://doi.org/10.1007/s002960050069.Search in Google Scholar PubMed
21. Halldorsdottir, HD, Jonsson, T, Thorsteinsson, J, Valdimarsson, H. A prospective study on the incidence of rheumatoid arthritis among people with persistent increase of rheumatoid factor. Ann Rheum Dis 2000;59:149–51. https://doi.org/10.1136/ard.59.2.149.Search in Google Scholar PubMed PubMed Central
22. van der Linden, MP, Batstra, MR, Bakker-Jonges, LE, Foundation for Quality Medical Laboratory Diagnostics, Detert, J, Bastian, H, et al.. Toward a data-driven evaluation of the 2010 American college of rheumatology/European league against rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor? Arthritis Rheum 2011;63:1190–9. https://doi.org/10.1002/art.30200.Search in Google Scholar PubMed
23. Bas, S, Perneger, TV, Kunzle, E, Vischer, TL. Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors. Ann Rheum Dis 2002;61:505–10. https://doi.org/10.1136/ard.61.6.505.Search in Google Scholar PubMed PubMed Central
24. Tuomi, T. Which antigen to use in the detection of rheumatoid factors? Comparison of patients with rheumatoid arthritis and subjects with ‘false positive’ rheumatoid factor reactions. Clin Exp Immunol 1989;77:349–55.Search in Google Scholar
25. van Hoovels, L, Vander Cruyssen, B, Sieghart, D, Bonroy, C, Nagy, E, Pullerits, R, et al.. Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results. RMD Open 2022;8:e002099. https://doi.org/10.1136/rmdopen-2021-002099.Search in Google Scholar PubMed PubMed Central
© 2023 Walter de Gruyter GmbH, Berlin/Boston
